Bulis Veronica Sanchez bought LYEL
February 10, 2026 · Form 4 insider transaction
Bulis Veronica Sanchez bought 8,750 shares of Lyell Immunopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,750
Price
$0.00
Total value
N/A
InsiderBulis Veronica Sanchez
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 10, 2026
Filing dateFebruary 11, 2026
Shares owned after15,891
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units granted under the Issuer's 2021 Equity Incentive Plan. 12.5% of the total number of restricted stock units will vest on August 9, 2026, and thereafter an additional 1/16th of the total number of restricted stock units will vest quarterly thereafter, subject to the reporting person providing service through the applicable vesting date.